I am a board-certified medical oncologist who specializes in treating patients with gastrointestinal cancers. I have a special interest in caring for patients with an inherited risk for colorectal cancer. I work very closely with a team of surgeons, oncologists, gastroenterologists, and radiation therapists to provide the best treatment and care for each patient. In addition, I have a separate genetics clinic where I provide clinical counseling and genetic testing for people who may have an inherited predisposition to gastrointestinal or other cancers. Based on genetic test results and family history, I help men and women with cancer incorporate genetic information into their treatment plan and the surveillance of cancer after treatment.
My research focuses on the discovery of novel cancer-susceptibility genes and the development of new approaches to cancer screening and prevention in high-risk families. I have received an American Society of Clinical Oncology Career Development Award, and more recently was honored to be selected for a Clinical Investigator Award by the Damon Runyon Cancer Research Foundation for my research on the genetic causes of cancer in patients with early-onset disease. Through funding secured via the National Institutes of Health, I am also studying genetic susceptibility in patients who have more then one malignancy. I am an active member of the American Society of Clinical Oncology and recently served as chair of its education committee on cancer genetics.
- Clinical Expertise: Colorectal Cancer; Gastrointestinal Oncology; Genetic Predisposition to Cancer; Cancer Risk Counseling
- Languages Spoken: English
- Education: MD, Weill Cornell Medical College
- Residencies: Brigham and Women's Hospital
- Fellowships: Beth Israel Deaconess Medical Center/Harvard Medical School
- Board Certifications: Internal Medicine; Medical Oncology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.